In the realm of fine chemicals, (S)-Ethyl 2-Hydroxy-4-phenylbutanoate, identified by CAS number 125639-64-7, is a compound of significant interest for chemists and researchers worldwide. Its molecular structure, C12H16O3, with a molecular weight of 208.25, offers a unique chiral center that is crucial for stereospecific reactions. This makes it an invaluable intermediate in the synthesis of complex organic molecules, particularly within the pharmaceutical industry. Manufacturers and suppliers specializing in chiral compounds often feature this ester in their catalogs, catering to the demanding needs of drug development and advanced material science.

The primary application driving demand for (S)-Ethyl 2-Hydroxy-4-phenylbutanoate lies in its use as a precursor for biologically active compounds. Specifically, it is instrumental in the synthesis pathways leading to benzofurans, benzothiophenes, and indoles. These heterocyclic compounds are foundational in developing pharmaceuticals that treat a range of conditions, including metabolic diseases like insulin resistance and hyperglycemia. When researchers look to buy this compound, they are often seeking a reliable source that can guarantee both consistent quality and availability for their experimental and production needs. The pricing and supply chain reliability from a reputable manufacturer are key considerations.

Beyond its role in therapeutic drug synthesis, the chemical properties of (S)-Ethyl 2-Hydroxy-4-phenylbutanoate, such as its density (approx. 1.075 g/mL) and flash point (150 °C), are important for handling and processing. Its solubility in solvents like chloroform and methanol further aids its utility in various reaction conditions. For companies involved in custom synthesis or looking for a trusted supplier of specialty chemicals, understanding the specifications and typical applications of compounds like this is essential. Engaging with a chemical manufacturer that prioritizes quality control and offers technical support can significantly enhance the efficiency of research and development efforts, making the purchase of such intermediates a strategic decision.